These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24269962)

  • 1. "Pharmacoperone": what's in a word?
    Conn PM; Ulloa-Aguirre A; Janovick JA
    Pharmacol Res; 2014 May; 83():1-2. PubMed ID: 24269962
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological chaperoning: a primer on mechanism and pharmacology.
    Leidenheimer NJ; Ryder KG
    Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule catalysts of oxidative protein folding.
    Lees WJ
    Curr Opin Chem Biol; 2008 Dec; 12(6):740-5. PubMed ID: 18824127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probe for every protein.
    Mullard A
    Nat Rev Drug Discov; 2019 Sep; 18(10):733-736. PubMed ID: 31570852
    [No Abstract]   [Full Text] [Related]  

  • 5. Unbiased binding assays for discovering small-molecule probes and drugs.
    Kemp MM; Weïwer M; Koehler AN
    Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 2).
    Wilson AJ; Gunning PT
    ChemMedChem; 2016 Apr; 11(8):732-3. PubMed ID: 27061459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation therapeutics.
    Carter PJ; Hazuda D; Wells JA
    Curr Opin Chem Biol; 2013 Jun; 17(3):317-9. PubMed ID: 23683350
    [No Abstract]   [Full Text] [Related]  

  • 10. Dendrimer space exploration: an assessment of dendrimers/dendritic scaffolding as inhibitors of protein-protein interactions, a potential new area of pharmaceutical development.
    Mignani S; El Kazzouli S; Bousmina MM; Majoral JP
    Chem Rev; 2014 Jan; 114(2):1327-42. PubMed ID: 24127777
    [No Abstract]   [Full Text] [Related]  

  • 11. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 1).
    Wilson AJ; Gunning PT
    Chembiochem; 2016 Apr; 17(8):644-5. PubMed ID: 27027879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein degradation for drug discovery.
    Ciulli A; Farnaby W
    Drug Discov Today Technol; 2019 Apr; 31():1-3. PubMed ID: 31200853
    [No Abstract]   [Full Text] [Related]  

  • 14. A biochemical screen for GroEL/GroES inhibitors.
    Johnson SM; Sharif O; Mak PA; Wang HT; Engels IH; Brinker A; Schultz PG; Horwich AL; Chapman E
    Bioorg Med Chem Lett; 2014 Feb; 24(3):786-9. PubMed ID: 24418775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency.
    Nyon MP; Gooptu B
    Future Med Chem; 2014 Jun; 6(9):1047-65. PubMed ID: 25068987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of misfolded proteins and stabilization by small molecules.
    Stevens RC; Sancho J; Martinez A
    Methods Mol Biol; 2010; 648():313-24. PubMed ID: 20700723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional screening of pharmacological chaperones via restoration of enzyme activity upon denaturation.
    Shanmuganathan M; Britz-McKibbin P
    Biochemistry; 2012 Oct; 51(39):7651-3. PubMed ID: 22970758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of small molecule inhibitors of protein-protein interactions using combined ligand and target score normalization.
    Casey FP; Pihan E; Shields DC
    J Chem Inf Model; 2009 Dec; 49(12):2708-17. PubMed ID: 19994847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Design of compound libraries for use in drug discovery].
    Orita M; Ohno K; Niimi T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1542-50. PubMed ID: 21089586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.